|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: UK (2003)) |
IUPAC Name ![]() |
| 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 3809 | acipimox |
Synonyms ![]() |
| Olbetam® |
Database Links ![]() |
|
| CAS Registry No. | 51037-30-0 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL345714 |
| PubChem CID | 5310993 |
| Search Google for chemical match using the InChIKey | DJQOOSBJCLSSEY-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | DJQOOSBJCLSSEY |
| Search PubMed clinical trials | acipimox |
| Search PubMed titles | acipimox |
| Search PubMed titles/abstracts | acipimox |
| Wikipedia | Acipimox |
| Comments |
| Acipimox is a nicotinic acid derivative. |